Better imaging detects glaucoma progression earlier

Article

It may be possible to view early changes in the eye before the clinical symptoms of glaucoma become apparent. A better understanding of the structural changes in glaucoma could potentially allow for a better diagnosis of the disease. Using imaging devices, such as the adaptive optics scanning laser ophthalmoscope (AOSLO), clinicians can view sharper and higher-resolution images of the eye than current clinical instruments.

 

Seattle-It may be possible to view early changes in the eye before the clinical symptoms of glaucoma become apparent. A better understanding of the structural changes in glaucoma could potentially allow for a better diagnosis of the disease, said Kevin M. Ivers, a PhD candidate at the College of Optometry, University of Houston.

Using the adaptive optics scanning laser ophthalmoscope (AOSLO), which takes sharper and higher-resolution images of the eye than current clinical instruments, Ivers and his team were able to view very early changes in the eye.

Speaking at the annual meeting of the American Academy of Optometry, Ivers discussed the results of a study involving non-human primates.

“The initial damage of glaucoma likely occurs in a tissue called the lamina cribosa, which lies in the optic nerve at the back of the eye,” Ivers said. “It is sponge-like tissue that provides structural and functional support to nerve fibers, which pass visual information to the brain.”

In 7 subjects, a change was seen in the lamina structure. In 4 subjects, increases in the anterior lamina cribosa surface depth (ALCSD) and mean pore parameters occurred prior to a change in the retinal nerve fiber layer (RNFL) thickness.

These changes thus occurred prior to clinical changes, Ivers said.

“To summarize,” he said, “We can see these changes in the lamina prior to changes in the RNFL thickness, and we can use high-resolution instruments to provide images of the lamina. We can track changes in disease progression during glaucoma.”

This will ultimately provide a better understanding of the disease mechanism along with the possibility of earlier diagnosis, Ivers concluded.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
© 2025 MJH Life Sciences

All rights reserved.